Found: 7
Select item for more details and to access through your institution.
Seven-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 577, doi. 10.1002/ajh.24040
- By:
- Publication type:
- Article
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 584, doi. 10.1002/ajh.24012
- By:
- Publication type:
- Article
Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 592, doi. 10.1002/ajh.24007
- By:
- Publication type:
- Article
Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 166, doi. 10.1002/ajh.23381
- By:
- Publication type:
- Article
Safety and efficacy of velaglucerase alfa in Gaucher disease type 1 patients previously treated with imiglucerase.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 172, doi. 10.1002/ajh.23383
- By:
- Publication type:
- Article
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 179, doi. 10.1002/ajh.23382
- By:
- Publication type:
- Article
Metachromatic Leukodystrophy.
- Published in:
- Journal of Child Neurology, 2016, v. 31, n. 13, p. 1457, doi. 10.1177/0883073816656401
- By:
- Publication type:
- Article